278 related articles for article (PubMed ID: 37833861)
1. Cytokines in Systemic Lupus Erythematosus-Focus on TNF-α and IL-17.
Richter P; Macovei LA; Mihai IR; Cardoneanu A; Burlui MA; Rezus E
Int J Mol Sci; 2023 Sep; 24(19):. PubMed ID: 37833861
[TBL] [Abstract][Full Text] [Related]
2. BAFF-R and TACI expression on CD3+ T cells: Interplay among BAFF, APRIL and T helper cytokines profile in systemic lupus erythematosus.
Salazar-Camarena DC; Ortíz-Lazareno P; Marín-Rosales M; Cruz A; Muñoz-Valle F; Tapia-Llanos R; Orozco-Barocio G; Machado-Contreras R; Palafox-Sánchez CA
Cytokine; 2019 Feb; 114():115-127. PubMed ID: 30467093
[TBL] [Abstract][Full Text] [Related]
3. Th1/Th2 cytokines in patients with systemic lupus erythematosus: is tumor necrosis factor alpha protective?
Gómez D; Correa PA; Gómez LM; Cadena J; Molina JF; Anaya JM
Semin Arthritis Rheum; 2004 Jun; 33(6):404-13. PubMed ID: 15190525
[TBL] [Abstract][Full Text] [Related]
4. Proinflammatory cytokines (TNF-alpha and IL-6) in Egyptian patients with SLE: its correlation with disease activity.
Sabry A; Sheashaa H; El-Husseini A; Mahmoud K; Eldahshan KF; George SK; Abdel-Khalek E; El-Shafey EM; Abo-Zenah H
Cytokine; 2006 Aug; 35(3-4):148-53. PubMed ID: 17027280
[TBL] [Abstract][Full Text] [Related]
5. The use of anti-TNF-alpha therapies for patients with systemic lupus erythematosus. Where are we now?
Lorenzo-Vizcaya A; Isenberg DA
Expert Opin Biol Ther; 2021 May; 21(5):639-647. PubMed ID: 33216641
[TBL] [Abstract][Full Text] [Related]
6. Melatonin Receptor 1β Gene Polymorphism rs10830963, Serum Melatonin, TNF-α, IL-6, IL-1β, in Egyptian Patients with Systemic Lupus Erythematosus.
Fayad A; Hassan E; Salem T
Egypt J Immunol; 2019 Jan; 26(1):101-112. PubMed ID: 31333000
[TBL] [Abstract][Full Text] [Related]
7. Correlation between levels of TNF-alpha and IL-6 and hematological involvement in SLE Egyptian patients with lupus nephritis.
Sabry A; Elbasyouni SR; Sheashaa HA; Alhusseini AA; Mahmoud K; George SK; Kaleek EA; abo-Zena H; Kalil AM; Mohsen T; Rahim MA; El-samanody AZ
Int Urol Nephrol; 2006; 38(3-4):731-7. PubMed ID: 17260180
[TBL] [Abstract][Full Text] [Related]
8. Crosstalk between miR-146a and pro-inflammatory cytokines in patients with systemic lupus erythematosus.
El-Akhras BA; Talaat RM; El-Masry SA; Bassyouni IH; El-Sayed IH; Ali YB
Int J Immunopathol Pharmacol; 2023; 37():3946320231154998. PubMed ID: 36740569
[TBL] [Abstract][Full Text] [Related]
9. The association of cytokines with disease activity and damage scores in systemic lupus erythematosus patients.
McCarthy EM; Smith S; Lee RZ; Cunnane G; Doran MF; Donnelly S; Howard D; O'Connell P; Kearns G; Ní Gabhann J; Jefferies CA
Rheumatology (Oxford); 2014 Sep; 53(9):1586-94. PubMed ID: 24706988
[TBL] [Abstract][Full Text] [Related]
10. Interleukin-25 is upregulated in patients with systemic lupus erythematosus and ameliorates murine lupus by inhibiting inflammatory cytokine production.
Li Y; Wang R; Liu S; Liu J; Pan W; Li F; Li J; Meng D
Int Immunopharmacol; 2019 Sep; 74():105680. PubMed ID: 31200339
[TBL] [Abstract][Full Text] [Related]
11. Relationship of oncogenes (sFas, Bcl-2) and cytokines (IL-10, alfa-TNF) with the activity of systemic lupus erythematosus.
Miret C; Font J; Molina R; Garcia-Carrasco M; Filella X; Ramos M; Cervera R; Ballesta A; Ingelmo M
Anticancer Res; 2001; 21(4B):3053-9. PubMed ID: 11712810
[TBL] [Abstract][Full Text] [Related]
12. Effects of anti-CD4 antibodies on the release of IL-6 and TNF-alpha in whole blood samples from patients with systemic lupus erythematosus.
Brink I; Thiele B; Burmester GR; Trebeljahr G; Emmrich F; Hiepe F
Lupus; 1999; 8(9):723-30. PubMed ID: 10602444
[TBL] [Abstract][Full Text] [Related]
13. Systemic Lupus Erythmatosus is Associated with Disturbed Cytokine Milieu and Increased TNF-Related Apoptosis-Induced Ligand Levels.
Saeed AM; Mogahed MM
Egypt J Immunol; 2016 Jun; 23(2):75-85. PubMed ID: 28502135
[TBL] [Abstract][Full Text] [Related]
14. MIF promotes a differential Th1/Th2/Th17 inflammatory response in human primary cell cultures: Predominance of Th17 cytokine profile in PBMC from healthy subjects and increase of IL-6 and TNF-α in PBMC from active SLE patients.
De la Cruz-Mosso U; García-Iglesias T; Bucala R; Estrada-García I; González-López L; Cerpa-Cruz S; Parra-Rojas I; Gámez-Nava JI; Pérez-Guerrero EE; Muñoz-Valle JF
Cell Immunol; 2018 Feb; 324():42-49. PubMed ID: 29397904
[TBL] [Abstract][Full Text] [Related]
15. Elevated interleukin-25 and its association to Th2 cytokines in systemic lupus erythematosus with lupus nephritis.
Selvaraja M; Abdullah M; Arip M; Chin VK; Shah A; Amin Nordin S
PLoS One; 2019; 14(11):e0224707. PubMed ID: 31697750
[TBL] [Abstract][Full Text] [Related]
16. Principal component analysis reveals disconnect between regulatory cytokines and disease activity in Systemic Lupus Erythematosus.
Raymond WD; Eilertsen GØ; Nossent J
Cytokine; 2019 Feb; 114():67-73. PubMed ID: 30551949
[TBL] [Abstract][Full Text] [Related]
17. Cytokine imbalance in systemic lupus erythematosus: a study on northern Indian subjects.
Arora V; Verma J; Marwah V; Kumar A; Anand D; Das N
Lupus; 2012 May; 21(6):596-603. PubMed ID: 22300832
[TBL] [Abstract][Full Text] [Related]
18. Increased IL-18 in patients with systemic lupus erythematosus: relations with Th-1, Th-2, pro-inflammatory cytokines and disease activity. IL-18 is a marker of disease activity but does not correlate with pro-inflammatory cytokines.
Amerio P; Frezzolini A; Abeni D; Teofoli P; Girardelli CR; De Pità O; Puddu P
Clin Exp Rheumatol; 2002; 20(4):535-8. PubMed ID: 12175109
[TBL] [Abstract][Full Text] [Related]
19. A2A adenosine receptor upregulation correlates with disease activity in patients with systemic lupus erythematosus.
Bortoluzzi A; Vincenzi F; Govoni M; Padovan M; Ravani A; Borea PA; Varani K
Arthritis Res Ther; 2016 Aug; 18(1):192. PubMed ID: 27566294
[TBL] [Abstract][Full Text] [Related]
20. IL-1β, IL-10 and TNF-α polymorphisms may affect systemic lupus erythematosus risk and phenotype.
Rzeszotarska E; Sowinska A; Stypinska B; Lutkowska A; Felis-Giemza A; Olesinska M; Puszczewicz M; Majewski D; Jagodzinski PP; Haładyj E; Paradowska-Gorycka A
Clin Exp Rheumatol; 2022 Sep; 40(9):1708-1717. PubMed ID: 35084314
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
